News
After the JPM Hype, a Reality Check: Why your 2026 Strategy Hinges on your Manufacturing Toolkit
2+ hour, 23+ min ago (282+ words) The banners are down, the last of the San Francisco fog has lifted, and the biotech world is collectively nursing its post-J.P. Morgan Healthcare Conference hangover. The promises of 2026 are grand: AI-driven discovery will revolutionize R&D. Multi-specifics will conquer "undruggable…...